Formulation and in Vitro Characterization of Bioactive Mesoporous Silica With Doxorubicin and Metronidazole Intended for Bone Treatment and Regeneration
AAPS PharmSciTech - Switzerland
doi 10.1208/s12249-017-0804-3
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 22, 2017
Authors
Publisher
Springer Science and Business Media LLC